Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH
VanEck Vectors Biotech ETF

  • Fund Description

    VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/24/17

    • 30-Day SEC Yield1

      0.44%
    • Total Net Assets

      $693.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/15/2017
  • Portfolio Composition (%)
    as of 02/24/17

    • % of Net Assets
    • Stocks

      99.91
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.09
  • Daily HoldingsDaily Holdings (%) as of 02/24/17

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Amgen Inc
    AMGN US
    524,514
    91,559,16413.21
    Celgene Corp
    CELG US
    625,678
    73,973,91010.67
    Gilead Sciences Inc
    GILD US
    1,002,228
    70,095,82610.11
    Allergan Plc
    AGN US
    254,524
    62,452,5549.01
    Biogen Inc
    BIIB US
    149,366
    42,588,7286.14
    Illumina Inc
    ILMN US
    231,778
    37,084,4805.35
    Incyte Corp
    INCY US
    277,378
    36,394,7675.25
    Vertex Pharmaceuticals Inc
    VRTX US
    375,485
    32,317,9944.66
    Biomarin Pharmaceutical Inc
    BMRN US
    349,069
    30,547,0284.41
    Alexion Pharmaceuticals Inc
    ALXN US
    225,135
    29,614,2584.27
    Quintiles Ims Holdings Inc
    Q US
    367,624
    28,542,3274.12
    Regeneron Pharmaceuticals Inc
    REGN US
    78,124
    28,203,5454.07
    Tesaro Inc
    TSRO US
    86,773
    16,217,8742.34
    Qiagen Nv
    QGEN US
    558,464
    15,715,1772.27
    Grifols Sa
    GRFS US
    741,048
    12,968,3401.87
    United Therapeutics Corp
    UTHR US
    83,576
    12,261,4351.77
    Charles River Laboratories Internationa
    CRL US
    135,795
    11,956,7501.73
    Alkermes Plc
    ALKS US
    199,632
    10,576,5031.53
    Ionis Pharmaceuticals Inc
    IONS US
    230,441
    10,275,3641.48
    Seattle Genetics Inc
    SGEN US
    151,692
    9,515,6391.37
    Acadia Pharmaceuticals Inc
    ACAD US
    221,898
    8,627,3941.24
    Neurocrine Biosciences Inc
    NBIX US
    183,186
    7,825,7061.13
    Alnylam Pharmaceuticals Inc
    ALNY US
    139,424
    6,499,9470.94
    Bluebird Bio Inc
    BLUE US
    43,492
    3,566,3440.51
    Intercept Pharmaceuticals Inc
    ICPT US
    25,728
    3,066,5200.44
    Other/Cash
    --
    --
    657,3550.09
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.